Top Markets
Coin of the day
Jinyu Bio-technology Co., Ltd. Jinyu Bio-technology Co., Ltd.

Jinyu Bio-technology Co., Ltd.

600201
Rank in Stocks #6431
Based in Hohhot, China, Jinyu Bio-technology Co., Ltd. is a Chinese firm... Based in Hohhot, China, Jinyu Bio-technology Co., Ltd. is a Chinese firm specializing in the development, production, and commercialization of biological products for animal health. Established in 1992, the company provides crucial vaccines designed to combat diseases such as foot-and-mouth disease, highly pathogenic avian influenza, brucellosis, rabies, and swine fever. These vital immunizations are supplied for a broad spectrum of animals, including pigs, poultry, ruminants, and companion pets. The entity formally adopted its current name, Jinyu Bio-technology Co., Ltd., in December 2015, having previously operated as Inner Mongolia Jinyu Group Co., Ltd.
Share Price
$1.85
Market Cap
$2.05B
Change (1 day)
0.63%
Change (1 year)
51.64%
Country
CN
Trade Jinyu Bio-technology Co., Ltd. (600201)

Category

Operating Margin for Jinyu Bio-technology Co., Ltd. (600201)
Operating Margin as of 2026 TTM: 0.00%
According to Jinyu Bio-technology Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Jinyu Bio-technology Co., Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
-149.01% -
US
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.